Christopher Rovaldi, SVP, Program Management and Operations at ACCELERON PHARMA INC (XLRN), sold 11,000 shares at $45.00 ($495K) on 2018-01-12, disclosed to the SEC on 2018-01-17.
Open-market sale of $495k XLRN by SVP, Program Management and Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| XLRN | SELL | 2018-04-04 | $245K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $157K | — | Filing → |
| XLRN | SELL | 2017-09-14 | $538K | — | Filing → |